Early Feasibility Study of the Edwards EVOQUE Tricuspid Valve Replacement System

Recruiting

18-99 years

All

45 participants needed

1 Location

Brief description of study

The goal of this study is to determine the safety and performance of the Edwards EVOQUE System in patients who experience at least moderate tricuspid regurgitation and signs of, or symptoms from or prior heart failure hospitalizations for tricuspid regurgitation.

Detailed description of study

Participants will be asked to complete the following research procedures: CT scan of heart, echocardiogram, electrocardiogram, blood work, neurological exam if a history of a stroke, pulmonary function test if history of lung disease, quality of life questionnaires, and six-minute walk test. Participants will also be asked to take blood-thinning medication. These procedures are described in more detail in the below informed consent form. Participation will last for approximately 5 years if participant receives the EVOQUE valve.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Heart,valve,cardiovascular
Age: Between 18 Years - 99 Years
Gender: All

Updated on 09 Mar 2024. Study ID: 842666

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).